Search Videos and More
Symposium
Breast Cancer Breakthroughs: SABCS 2025 Highlights
Experts in Dana-Farber’s Breast Oncology Center discuss highlights in breast cancer research innovation presented at SABCS 2025 in San Antonio, Texas, including what the data mean, how it can be used in clinic, and what’s next in the field of breast cancer research.
News
The Gene Fixer
For five decades, Stuart Orkin has harnessed new genetic tools to transform care for blood disorders – helping make sickle cell and beta thalassemia curable.
News
Dana-Farber Research Uncovers Approach to Activating the Immune System Against Metastatic Breast Cancer
Cancer spreads, or metastasizes, when tumor cells shed from a primary solid tumor, for example in the breast, and embed in other organs, such as the lung, liver, and brain, and begin to grow.
News
Dana-Farber Researchers Join Global Cancer Grand Challenges Team Taking on the Dark Proteome
A global, interdisciplinary team of researchers including Dana-Farber’s Cathy Wu, MD, and William Freed-Pastor, MD, PhD, have been selected to receive a Cancer Grand Challenges award of up to $25m over five years to tackle the dark proteome challenge.
Symposium
Our Ambulatory Cell Therapies Clinic
Our growing outpatient cell therapies program enables many patients to receive stem cell transplant and CAR T-cell therapies without a lengthy hospital admission. Through this program, patients receive the same high-quality, comprehensive care – conditioning chemotherapy, cell infusion, and follow-up monitoring – in our Ambulatory Cell Therapies Clinic and return home or to nearby accommodations each day during their treatment period.
News
Dana-Farber Research News 03.01.2026
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from February 1 - 15.
News
Dana-Farber Research News 02.15.2026
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from January 16 - 31.
News
Dana-Farber, Gustave Roussy to Host Fifth Transatlantic Exchange in Oncology Focused on Cancer Drug Innovation
Dana-Farber Cancer Institute will host the Fifth Transatlantic Exchange in Oncology on Friday, March 27, 2026, bringing together leading cancer researchers and clinicians from the United States and Europe to explore transatlantic innovations in cancer drug research.
News
Making Breakthroughs in ALL From Youth to Adulthood
When Ann Carroll was diagnosed with cancer at age 28, her dream to get married and have a baby felt out of reach. Now, seven years later and cancer-free, she is living that dream with her husband and their 7-month-old son, Teddy.
News
Cell-Death Safety Net a Potential New Cancer Target
In the rare event that an elevator cable breaks, modern buildings have additional fail-safe mechanisms. For example, counterweight and mechanical brakes prevent the car from plummeting to the ground.
News
Dana-Farber Launches Colorectal Cancer Screening Program in Central Asia
Dana-Farber Cancer Institute's Center for Global Health launched the first colorectal cancer screening program in Central Asia this week, partnering with Uzbekistan’s Ministry of Health and National Cancer Center to pilot a sustainable, early detection model that could be scaled across the region.
News
Dana-Farber Research Helps Drive FDA Label Update for Primary CNS Lymphoma
Change removes prior exclusion and may expand access to CAR T-cell therapy for eligible relapsed or refractory patients